- Poster presentation
- Open Access
MiBalert, a realtime alert of multidrug-resistant bacteria in the electronic medical record
© Olesen et al; licensee BioMed Central Ltd. 2015
- Published: 16 June 2015
- Electronic Health Record
- Capital Region
- Improve Patient Safety
- Test Report
- Electronic Health Record System
When patients are readmitted or transferred between departments or hospitals, information on multiresistant microorganisms is often recognized late or lost, resulting in infection or colonization of fellow patients or even hospital outbreaks. Currently, the hospitals of the Capital region, covering 1.8 million inhabitants, face an outbreak of vancomycin resistant Enterococcus fæcium (VRE). All hospitals share the same EHR system.
To establish a nationwide automatic real time alert in electronic health records (EHR) of cases with multiresistant microorganisms. In 2015 a prototype alert was launched alerting cases with VRE in the Capital region. Here we share our first experiences.
Positive test report of VRE (red MiBAlert symbol)
No positivetest reports of VRE (green MiBa symbol)
Malfunction (grey X symbol)
By Mouse-over, a text shows the date of the positive VRE identification. A click on the smart button connects the doctor to MiBa, providing directly access to all the patients’ microbiological reports.
Staff at the emergency departments found that MiBAlert effectively highlighted VRE cases
The hygiene team reported of earlier recognition of VRE cases at sector transmissions
Staff at departments of radiology, medicine and outpatient clinics found MiBAlert very helpful
The prototype alerting VRE-cases was a success
MiBAlert improves patient safety, in particular during sector transmissions
MiBAlert is a valuable tool fighting the nosocomial VRE outbreak
MiBAlert is based on a national database and can easily be implemented nationwide
Soon other multiresistant bacteria will be included in MiBAlert
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.